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Permanent tattooing, has gained tremendous popularity 
for the past 20 years among the Western population. In 
Europe, the prevalence of tattoos is estimated around 
10% (1, 2), with the highest prevalence among the 20–35 
years old (25%) (2). In Finland, it is currently estimated 
that 15% of the 20–30-year-old individuals are tattooed 
(3). Tattoo inks are currently a combination of organic 
dyes, metallic salts and various additives including 
solvents, such as isopropanol, and preservatives (4). 
Several publications have shed light on possible toxic 
or carcinogenic compounds that could be introduced in 
the skin or develop in situ as by-products under various 
conditions (such as UV light or laser exposure) (5–8). It 
is only recently that European countries and the council 
of Europe have started to take actions regarding the tat-
too ink marketing, especially by withdrawing some inks 
that contained potential hazardous components from the 
market (9). However, the composition of tattoo inks is 
still not subjected to a strict homogenous regulation. Also, 
there is currently no test available to assess the safety of 
inks for the purpose of tattooing. Despite accumulation 
of the dye to local lymph nodes, which is a well-known 
consequence of tattooing (7, 10), the potential local and 
systemic carcinogenic effects of tattoos and tattoo inks 
remain to date unclear. We report here two additional 
cases of melanoma that developed on tattoos in two 
Finnish patients.
CASE REPORTS
Patient 1. In June 2006, a 61-year-old Caucasian Finnish man 
presented with an inflammatory ulcerated tumoural plaque of 
the right thigh overlying an old tattoo. Upon examination, a 
superficial, extensive, heterogenous and asymmetric pigmented 
lesion underlied and surrounded the tumour lesion (Fig. 1A). 
According to the patient, the pigmented lesion evolved during 
the past 5 years. Complete physical examination and full body 
computed tomography scan were normal. Excision of the lesion 
confirmed the diagnosis of superficial spreading melanoma 
with a nodular component (Breslow thickness 15 mm, Clark 
level IV). Sentinel lymph node exploration was negative. No 
relapse had occurred before 2009, after which no information 
was available. 
Patient 2. In May 2012, a 32-year-old Caucasian Finnish man 
presented with a 1.3 cm brown, polychromatic, asymmetric 
lesion on the upper back within a large black tattoo performed 
a couple of years earlier (Fig. 1B and C). The 
patient acknowledged that a small naevus 
pre-existed before tattooing and gradually 
changed during the following years. Howe-
ver, careful examination revealed that only 
the borders of the pigmented lesion reached 
the tattoo drawing. Physical examination 
was otherwise normal. Pathology of the 
surgically removed mole confirmed the 
diagnosis of a non-ulcerated superficially 
spreading type melanoma (Breslow thick-
ness 0.4 mm, Clark level II). Tattoo pigments 
were mainly located on the upper part of the 
papillary dermis, mainly around capillaries, 
on both spared edge of the excision margins. 
Very few dark pigments were found at the 
very same location as the tumoural area, 
confirming that the tattooist had most likely 
avoided tattooing over the initial pigmented 
lesion. The patient has been symptom-free 
for 12 months.
DISCUSSION
From 1938 until now, approximately 
50 cases of skin cancers have been 
reported on tattoos, including 16 me-
lanomas (for review see ref 11). Cur-
rently, the development of melanoma 
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Fig. 1. Case 1. Inflammatory ulcerated 
tumoural plaque of the right thigh 
overlying an old tattoo: nodular 
melanoma overlying a superficial 
spreading melanoma (A). Case 2. 
Superficial spreading melanoma within 
a tribal tattoo of the back (B). Close up 
view of the lesion (C).
326 Short communication
and non-melanoma skin cancers on tattoos is still 
considered as fortuitous. This position is supported by 
several arguments: (i) the rather low number of reported 
cases compared to the number of tattooed individuals 
worldwide; (ii) as the prevalence of tattoos and mela-
noma both increase in the general population, among 
the young especially, the risk of a coincidental lesion 
increases as well. In other words, the risk of having a 
coincidental melanoma on a tattoo increases with the 
surface of skin that is tattooed; (iii) the absence – so far 
– of cases of multiple melanoma occurring within the 
same tattoo, which would be a strong signal for a link, 
in the absence of any other risk factor for melanoma. 
Another indirect argument against a link can be taken 
for our cases. Indeed, if we consider that tattoo inks do 
contain carcinogenic compounds, one would expect a 
quantitative effect, i.e. the more ink that is tattooed in 
the skin, the higher the concentration of carcinogenic 
components, and the higher the risk of cancer. Howe-
ver, the tattoo of the first patient was only made of thin 
drawings with no shadings or filling (Fig. 1A), therefore 
the concentration of tattooed pigments was here quite 
low. In our second case, it was impossible to determine 
whether the preexisting mole was already a de novo 
melanoma or a naevus that transformed secondarily. 
Some tattoo pigments were found within the melanoma 
on the sides of the lesion, most likely coincidentally, 
because the malignant process has extended slowly 
towards the tattoo.
Although, the incidence of skin cancer on tattoos 
remains low (11), a notable exception concerns keratoa-
canthomas (12, 13) known for its proneness to develop 
quickly within a recent traumatised area (14). It should 
also be noted the curiosity that keratoacanthomas have 
mainly been reported within the red parts of tattoos (11), 
while most of the cases of melanomas have developed 
within dark tattoos, as in our cases. Indeed, Regensbur-
ger et al. (8) found aromatic polycyclic hydrocarbures 
in some black inks, some of them being classified as 
carcinogen 2B. However, we think that, rather than ha-
ving a true and direct carcinogenic effect, dark tattoos 
may simply mask the clinical malignant modifications 
and delay clinical diagnosis. The ugly duckling sign is 
more difficult to detect and, lastly, in our experience, 
dermoscopy is more difficult because of the exogenous 
pigmentation (15). 
It is highly debatable to suggest to any person wishing 
to have a tattoo to go to a dermatologist first. However, 
patients with numerous moles, atypical mole syndrome 
and familial history of melanoma should definitely 
seek advice to a dermatologist before tattooing (15). 
Similarly, tattooists should be careful before tattooing a 
patient with numerous moles. They should be educated 
that, in doubt, they should delay the procedure and refer 
the customer for advice to a dermatologist.
Incidentally, we strongly recommend that the patho-
logists always use the ICD code for tattoo pigmentation 
(2013 ICD-10-CM diagnosis code L81.8) in case of any 
tumour arising on a tattoo so that future epidemiological 
studies regarding the risk of cancer on tattoos can be 
performed easily in national cancer registries.
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